Cancer BiologybioRxiv
Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas
E. N. Bonglack, J. E. Messinger, J. M. Cable…·M. A. Luftig
This study shows that inhibiting MCT1 and MCT4 in EBV-driven lymphomas disrupts metabolism, leading to growth arrest and sensitization to metformin, revealing a potential therapeutic strategy.
DOI 10.1073/pnas.2022495118